Ketamine for Relapse Prevention in Recurrent Depressive Disorder
Status:
Terminated
Trial end date:
2018-05-23
Target enrollment:
Participant gender:
Summary
Randomised, controlled, parallel-group, pilot clinical trial of ketamine vs. midazolam for
depression relapse prevention in persons at high risk. The main purpose of the pilot study is
to assess trial processes to help inform a future definitive trial.